Understanding the distinct roles of p53 family of transcription factors through identification of protein-protein interactions

被引：0
|
作者：
Maiorov, E. Guven [1 ,2 ]
King, K. [1 ]
Sakakibara, N. [1 ]
Matar, H. [1 ]
Ponnamperuma, R. [1 ]
Weinberg, W. [1 ]
机构：
[1] US FDA, CDER, OBP, Silver Spring, MD USA
[2] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
057
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [41] Novel protein–protein interactions of TPPII, p53, and SIRT7
    Jarmila Nahálková
    Molecular and Cellular Biochemistry, 2015, 409 : 13 - 22
  • [42] Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53
    Updesh Dixit
    Zhihe Liu
    Ashutosh K Pandey
    Ramesh Kothari
    Virendra N Pandey
    BMC Cancer, 14
  • [43] Insight on Heterocycles as p53-MDM2 Protein-Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation
    Basha, N. Jeelan
    Mohan, R. M.
    CHEMISTRYSELECT, 2024, 9 (10):
  • [44] Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53
    Dixit, Updesh
    Liu, Zhihe
    Pandey, Ashutosh K.
    Kothari, Ramesh
    Pandey, Virendra N.
    BMC CANCER, 2014, 14
  • [45] Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors
    El-Tanani, M
    Fernig, DG
    Barraclough, R
    Green, C
    Rudland, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) : 41675 - 41682
  • [46] Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1
    Tong, Xin
    Xu, Dandan
    Mishra, Rama K.
    Jones, Ryan D.
    Sun, Leyu
    Schiltz, Gary E.
    Liao, Jie
    Yang, Guang-Yu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [47] Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein
    Chi, WJ
    Doong, SL
    Lin-Shiau, SY
    Boone, CW
    Kelloff, GJ
    Lin, JK
    CARCINOGENESIS, 1998, 19 (12) : 2133 - 2138
  • [48] Design and synthesis of dual inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions
    Adhikari, Santosh
    Cano, Celine
    Golding, Bernard
    Hardcastle, Ian
    Harnor, Suzannah
    Jennings, Claire
    Lunec, John
    Myers, Stephanie
    Newell, D.
    Reeks, Judith
    Shouksmith, Andrew
    Tudhope, Sue
    Wedge, Steve
    Willmore, Elaine
    Wittner, Anita
    Zhao, Yan
    Griffin, Roger
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [49] Inhibitors of the p53/hdm2 protein-protein interaction-path to the clinic
    Carry, Jean-Christophe
    Garcia-Echeverria, Carlos
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2480 - 2485
  • [50] Functional dissection of an intrinsically disordered protein: Understanding the roles of different domains of Knr4 protein in protein-protein interactions
    Dagkessamanskaia, Adilia
    Durand, Fabien
    Uversky, Vladimir N.
    Binda, Matteo
    Lopez, Frederic
    El Azzouzi, Karim
    Francois, Jean Marie
    Martin-Yken, Helene
    PROTEIN SCIENCE, 2010, 19 (07) : 1376 - 1385
12345